Sam Brusco, Associate Editor03.28.23
Vyaire Medical has agreed to sell its Vyaire consumable businesses to SunMed, a North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care. Terms of the deal were not disclosed.
The Vyaire consumables portfolio is comprised of airway management and operative care technology such as brands AirLife oxygen therapy, Vital Signs anesthesia circuits, and SuperNO2VA nasal PAP ventilation.
"This divestiture allows Vyaire to focus on its industry-leading respiratory diagnostics and ventilation businesses and accelerate our strategic growth plans," Gaurav Agarwal, CEO of Vyaire told the press. "Uniting the industry-leading Vyaire consumables portfolio with SunMed's compatible suite of products is a win-win for both companies, as well as customers and patients, and will enhance the potential for long-term growth of the combined consumables portfolio."
"We are extremely pleased with this transaction, which will empower Vyaire to focus squarely on its specialty in respiratory diagnostics and ventilation moving forward, cementing its position as a market leader in this space," said Steven Dyson, partner at Apax. "We look forward to working with the Vyaire team on this exciting new chapter for the business."
After the transaction is completed, the combined businesses will form a dedicated manufacturer of respiratory and anesthesia consumables. Vyaire will fully manage its consumables business and products until the transaction is finalized.
The Vyaire consumables portfolio is comprised of airway management and operative care technology such as brands AirLife oxygen therapy, Vital Signs anesthesia circuits, and SuperNO2VA nasal PAP ventilation.
"This divestiture allows Vyaire to focus on its industry-leading respiratory diagnostics and ventilation businesses and accelerate our strategic growth plans," Gaurav Agarwal, CEO of Vyaire told the press. "Uniting the industry-leading Vyaire consumables portfolio with SunMed's compatible suite of products is a win-win for both companies, as well as customers and patients, and will enhance the potential for long-term growth of the combined consumables portfolio."
"We are extremely pleased with this transaction, which will empower Vyaire to focus squarely on its specialty in respiratory diagnostics and ventilation moving forward, cementing its position as a market leader in this space," said Steven Dyson, partner at Apax. "We look forward to working with the Vyaire team on this exciting new chapter for the business."
After the transaction is completed, the combined businesses will form a dedicated manufacturer of respiratory and anesthesia consumables. Vyaire will fully manage its consumables business and products until the transaction is finalized.
